Kura Oncology, Inc.
DE ˙ DB ˙ US50127T1097
7,56 € ↑0,24 (3,28%)
2026-06-05
DEL PRIS
SecurityDE:KUR / Kura Oncology, Inc.
InstitutionHsbc Holdings Plc
Latest Disclosed Ownership89,032 shares
Latest Disclosed Value $ 736,295
Hsbc Holdings Plc reports 71.21% increase in ownership of KUR / Kura Oncology, Inc.

On April 30, 2026 - Hsbc Holdings Plc filed a 13F-HR form disclosing ownership of 89,032 shares of Kura Oncology, Inc. (DE:KUR) valued at $592,063 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on March 20, 2026 disclosing 52,003 shares of Kura Oncology, Inc.. This represents a change in shares of 71.21% during the quarter. The current value of the position is $673,082 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-30 2026-03-31 13F KURA ONCOLOGY COM 50127T109 89,032 37,029 71.21 736 37.31 0.0001
2026-03-20 2025-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 52,003 -79,189 -60.36 536 -53.35 0.0000
2026-03-06 2025-12-31 13F KURA ONCOLOGY COM 50127T109 52,003 -79,189 -60.36 536 -53.35 0.0000
2025-11-13 2025-09-30 13F KURA ONCOLOGY COM 50127T109 131,192 -5,884 -4.29 1,149 46.56 0.0001
2025-08-13 2025-06-30 13F KURA ONCOLOGY COM 50127T109 137,076 82,585 151.56 784 123.36 0.0005
2025-05-14 2025-03-31 13F KURA ONCOLOGY COM 50127T109 54,491 11,406 26.47 351 -5.14 0.0002
2025-02-14 2024-12-31 13F KURA ONCOLOGY COM 50127T109 43,085 26,922 166.57 370 17.46 0.0002
2024-11-14 2024-09-30 13F KURA ONCOLOGY COM 50127T109 16,163 -2,137 -11.68 316 -15.55 0.0002
2024-08-12 2024-06-30 13F KURA ONCOLOGY COM 50127T109 18,300 2,167 13.43 374 8.43 0.0002
2024-05-15 2024-03-31 13F KURA ONCOLOGY COM 50127T109 16,133 -21,693 -57.35 344 -36.76 0.0002
2024-02-12 2023-12-31 13F KURA ONCOLOGY COM 50127T109 37,826 4,589 13.81 545 81.94 0.0005
2023-11-13 2023-09-30 13F KURA ONCOLOGY COM 50127T109 33,237 33,237 300 0.0003
2021-05-14 2021-03-31 13F KURA ONCOLOGY COM 50127T109 0 -6,147 -100.00 0 -100.00
2021-02-25 2020-12-31 13F/A-1 KURA ONCOLOGY COM 50127T109 6,147 6,147 204 0.0003
2021-02-12 2020-12-31 13F KURA ONCOLOGY COM 50127T109 6,147 6,147 204
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.